UASt regulatory sequences drive expression of an inverted repeat.
Scer\GAL4tj-NP1624-mediated expression results in the transformation of the normal germline cyst epithelial monolayer into two or more cell layers.
Expression of α-SpecKK101541 under the control of Scer\GAL4elav.PU results in synaptic retractions in 47% of muscle 6/7 synapses.
Expression of α-SpecKK101541 under the control of Scer\GAL4elav-C155 results in synaptic degeneration.
α-SpecKK101541, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, enhanceable by bskK53R.UAS, Scer\GAL4elav-C155
α-SpecKK101541, Scer\GAL4elav.PU has abnormal neuroanatomy | larval stage phenotype, suppressible by SkpAGD65
α-SpecKK101541, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, suppressible by MiroB682
α-SpecKK101541, Scer\GAL4elav-C155 has embryonic/larval neuromuscular junction phenotype, enhanceable by bskK53R.UAS, Scer\GAL4elav-C155
α-SpecKK101541, Scer\GAL4elav.PU has embryonic/larval neuromuscular junction | larval stage phenotype, suppressible by SkpAGD65
α-SpecKK101541, Scer\GAL4elav-C155 has embryonic/larval neuromuscular junction phenotype, suppressible by MiroB682
Scer\GAL4elav-C155/α-SpecKK101541 is a non-enhancer of mitochondrion phenotype of MiroB682
The synaptic retraction phenotype seen at the neuromuscular junction in larvae expressing α-SpecKK101541 under the control of Scer\GAL4elav.PU is suppressed by SkpAGD65.
Expression of bskK53R.Scer\UAS enhances the synaptic degeneration phenotype seen when α-SpecKK101541 is expressed under the control of Scer\GAL4elav-C155.
Homozygous MiroB682 suppresses the neuromuscular degeneration seen when α-SpecKK101541 is expressed under the control of Scer\GAL4elav-C155. The decrease in the number of mitochondria seen in MiroB682 mutants is also seen in these larvae.